Genprex, Inc. (GNPX)
0.783
-0.02
(-2.73%)
USD |
NASDAQ |
May 19, 14:19
Genprex EPS Diluted (Quarterly) : -0.6418 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.462M |
| Total Expenses (Quarterly) | 4.462M |
| Enterprise Value | -10.77M |
| Earnings Yield | -1.95K% |
| Normalized Earnings Yield | -1948.90 |